跳至主要内容
临床试验/NCT02761408
NCT02761408Unknown不适用

Correlation Between Radiation Dermatitis/Mucositis and ALDH2 Mutation in Taiwanese Head and Neck Cancer

Taipei Veterans General Hospital, Taiwan1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2016年4月最近更新:
适应症

试验速览

阶段
不适用
入组人数
120
试验地点
1
主要终点
Number of participants with treatment-related adverse events assessed by CTCAEv5.0

研究概览

简要总结

The purpose of this study is to evaluate the effect of ALDH2 mutation in radiation associating dermatitis or mucositis in head and neck cancer patients who accept chemoradiation therapy

详细描述

  • One-site audit. The enrolled subject is confirmed by PIs

◦◦Source data is compared to external data sources medical records, either paper or electronic case report forms.

  • NCI CTCAE v5.0 for AE records
  • Patient recruitment according to inclusion criteria: 1. Newly diagnosed locally head and neck squamous cell carcinoma; 2. Apply for primary chemoradiation or adjuvant chemoradiation; 3. Signed informed consent
  • Sample size assessment: 60 subjects will be included in one year for total 120 subjects
  • Missing data to address situations where variables are reported as missing, unavailable, "non-reported," uninterpretable, or considered missing because of data inconsistency or out-of-range results
  • Fisher's exact test is for category comparison. Kaplan-Meier analysis is for survival analysis. AE grades will be analyzed according to NCI guideline. Two-side p < 0.05 is suggested significant.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >20, <70
  • Newly diagnosed head and neck squamous cell carcinoma
  • Tissue proved
  • Signed informed consent
  • Suitable for chemoradiation

排除标准

  • Uncontrolled underlying diseases
  • Allergy to chemotherapy
  • Uncontrolled skin diseases or mucosa diseases
  • Previously radiation therapy over head and neck
  • Combined with other cancer currently

结局指标

主要结局

Number of participants with treatment-related adverse events assessed by CTCAEv5.0

时间窗: 6 months after the end of the study

The side effects of each participant will be recorded accoiding to CTCAEv5.0 during the whole course of chemoradiation, by indicated physicians regularly

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验